Pharmacotherapy of Stereotypes in Autism
https://doi.org/10.30629/2618-6667-2024-22-5-87-93
Abstract
Background: stereotypes are non specific manifestations of mental illnesses of various etiologies. Stereotypes affect the dynamics and severity of the manifestations of the underlying disease and require drug therapy. The aim of the study is to analyze published studies on pharmacotherapy of stereotypes in people with autism. Materials and Methods: according to the keywords “autism”, “autism spectrum disorder”, “stereotypes”, “stereotypic movements”, “repetitive actions”, “habitual movements”, “treatment effectiveness”, articles in English and Russian were searched in the databases MEDLINE/PubMed, Scopus, Web of Science, eLibrary for the period from 2005 to 2024. Conclusion: an analysis of published works has shown that there is no specific drug therapy for stereotypes in autism spectrum disorders to date. It is still not clear how appropriate an attempt to reduce stereotypical actions is, taking into account existing theories about the self-regulating role of repetitive behavior. The medical elimination of stereotypes is necessary when they reach the level of violence, severe obsession, hinder purposeful activity and the implementation of psychological and pedagogical correction.
About the Authors
L. Zh. Attaeva
SBIH “Psychiatric Hospital no. 1 Named after N.A. Alexeev of the Department of Health of Moscow”, Neuropsychiatric clinic No. 1
Russian Federation
Russian Federation
Leila Zh. Attaeva, Cand. Sci. (Med.), psychiatrist
Moscow
I. V. Makarov
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology; North-Western State Medical University named after I.I. Mechnikov
Russian Federation
Russian Federation
Igor V. Makarov, Dr. Sci. (Med.), Professor, Head of Department, Department of Child Psychiatry; Professor
St. Petersburg
References
1. Mukaetova-Ladinska EB, Simashkova NV, Mukaetova MS, Ivanov MV, Boksha IS. Autism spectrum disorders in children and adults: the experience of researches from different countries. S.S. Korsakov Journal of Neurology and Psychiatry. 2018; 118(12):92-99. (In Russ.). doi: 10.17116/jnevro201811812192
2. Maenner MJ, Shaw KA, Bakian AV, Bilder DA, Durkin MS, Esler A, Furnier SM, Hallas L, Hall-Lande J, Hudson A, Hughes MM, Patrick M, Pierce K, Poynter JN, Salinas A, Shenouda J, Vehorn A, Warren Z, Constantino JN, DiRienzo M, Fitzgerald RT, Grzybowski A, Spivey MH, Pettygrove S, Zahorodny W, Ali A, Andrews JG, Baroud T, Gutierrez J, Hewitt A, Lee LC, Lopez M, Mancilla KC, McArthur D, Schwenk YD, Washington A, Williams S, Cogswell ME. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018. MMWR Surveill Summ. 2021 Dec 3;70(11):1-16. doi: 10.15585/mmwr.ss7011a1
3. Zeidan J, Fombonne E, Scorah J, Ibrahim A, Durkin MS, Saxena S, Yusuf A, Shih A, Elsabbagh M. Global prevalence of autism: A systematic review update. Autism Res. 2022 May; 15(5):778-790. doi: 10.1002/aur.2696
4. Makushkin EV, Makarov IV, Pashkovskij VE. The prevalence of autism: concrete and imaginary. S.S. Korsakov Journal of Neurology and Psychiatry. 2019; 119(2):80-86. (In Russ.). doi: 10.17116/jnevro201911902180
5. Kazakovcev BA, Demcheva NK, Yazdovskaya AV, Sidoryuk OV, Nikolaeva TA. Psychiatric care for the population of the Russian Federation in 2019. Analytical review. M., 2020. 145 s.
6. Attaeva LZh, Makarov IV. Stereotypes in children. Social and clinical psychiatry. 2021;31(2):79-85. (In Russ.).
7. Zandt F, Prior M, Kyrios M. Similarities and differences between children and adolescents with autism spectrum disorder and those with obsessive compulsive disorder: executive functioning and repetitive behaviour. Autism. 2009 Jan;13(1):43-57. doi: 10.1177/1362361308097120
8. Carrasco M, Volkmar FR, Bloch MH. Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias. Pediatrics. 2012; 129(5):e1301-1310. doi: 10.1542/peds.2011-3285
9. Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry. 1993;50(6):441-447. doi: 10.1001/archpsyc.1993.01820180039004
10. McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry. 1996;53(11):1001-1008. doi: 10.1001/archpsyc.1996.01830110037005
11. Remington G, Sloman L, Konstantareas M, Parker K, Gow R. Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study. J Clin Psychopharmacol. 2001;21(4):440-444. doi: 10.1097/00004714-200108000-00012
12. Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, Iyengar R. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 2005;30(3):582-589. doi: 10.1038/sj.npp.1300627.
13. King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L; STAART Psychopharmacology Network. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry. 2009;66(6):583-590. doi: 10.1001/archgenpsychiatry.2009.30
14. Dichter GS. Functional magnetic resonance imaging of autism spectrum disorders. Dialogues. Clin Neurosci. 2012 Sep;14(3):319-351. doi: 10.31887/DCNS.2012.14.3/gdichter
15. McDougle CJ, Kresch LE, Posey DJ. Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors. J Autism Dev Disord. 2000; 30(5):427-435. doi: 10.1023/a:1005551523657
16. Herscu P, Handen BL, Arnold LE, Snape MF, Bregman JD, Ginsberg L, Hendren R, Kolevzon A, Melmed R, Mintz M, Minshew N, Sikich L, Attalla A, King B, Owley T, Childress A, Chugani H, Frazier J, Cartwright C, Murphy T; Autism Speaks Autism Clinical Trials Network. The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder. J Autism Dev Disord. 2020; 50(9):3233-3244. doi: 10.1007/s10803-019-04120-y
17. Cook EH Jr, Rowlett R, Jaselskis C, Leventhal BL. Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry. 1992;31(4):739-745. doi: 10.1097/00004583-199207000-00024
18. Carrasco M, Volkmar FR, Bloch MH. Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias. Pediatrics. 2012; 129(5):e1301-1310. doi: 10.1542/peds.2011-3285
19. Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, Iyengar R. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 2005;30(3):582-589. doi: 10.1038/sj.npp.1300627
20. King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L; STAART Psychopharmacology Network. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry. 2009;66(6):583-590. doi: 10.1001/archgenpsychiatry.2009.30
21. Miral S, Gencer O, Inal-Emiroglu FN, Baykara B, Baykara A, Dirik E. Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial. Eur Child Adolesc Psychiatry. 2008 Feb;17(1):1-8. doi: 10.1007/s00787-007-0620-5
22. Jesner OS, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database Syst Rev. 2007;2007(1):CD005040. doi: 10.1002/14651858
23. Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, Aman MG. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1110-1119. doi: 10.1097/CHI.0b013e3181b76658. PMID: 19797985.
24. Amminger GP, Berger GE, Schäfer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry. 2007; 61(4):551-553. doi: 10.1016/j.biopsych.2006.05.007.
Review
For citations:
Attaeva L.Zh., Makarov I.V. Pharmacotherapy of Stereotypes in Autism. Psychiatry (Moscow) (Psikhiatriya). 2024;22(5):87-93. (In Russ.) https://doi.org/10.30629/2618-6667-2024-22-5-87-93
Views:
216
Email this article 
